|
1.
|
Phase I trial of a new schedule of romidepsin in patients with advanced cancers. MedStar authors:
Citation: - Clinical Cancer Research. 19(16):4499-507, 2013 Aug 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
All authors: - Amiri-Kordestani L, Bates SE, Draper D, Figg WD, Fojo T, Frye R, Ghafourian K, Luchenko V, Peer CJ, Piekarz RL, Reynolds J, Skarulis M, Venzon D, Woo S, Wright J
|
|
2.
|
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
|